Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
- 1 January 1993
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 114 (1) , 49-55
- https://doi.org/10.1016/0022-510x(93)90048-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990
- Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathyJournal of Neuroimmunology, 1989
- Motor dominant neuropathy and IgM paraproteinemia: the IgM M-protein binds to specific gangliosidesJournal of Neuroimmunology, 1989
- Identification and Characterization of Gangliosides Reacting with IgM Paraproteins in Three Patients with Neuropathy Associated with Biclonal GammopathyJournal of Neurochemistry, 1988
- Occurrence and isotype of antibodies against peripheral nerve myelin in serum from patients with peripheral neuropathy and healthy controls.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Serum antibodies to gangliosides in guillain‐barré syndromeAnnals of Neurology, 1988
- Clinical correlation with anti‐peripheral‐nerve myelin antibodies in Guillain‐Barré syndromeAnnals of Neurology, 1986
- Plasmapheresis and acute Guillain‐Barre syndromeNeurology, 1985
- Estimation of IgM in cerebrospinal fluid by enzyme immunoassayClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHYThe Lancet, 1978